Global Contract Pharmaceutical Manufacturing Market Insights: Impact of COVID-19 and Future Expectations to 2025
The Contract Pharmaceutical Manufacturing market revenue was 85598 Million USD in 2019, and will reach 127527 Million USD in 2025, with a CAGR of 6.87% during 2020-2025. Contract Pharmaceutical Manufacturing is a process of outsourcing certain production activities to third party manufacturers. These manufacturers are given the chemical formulation by pharma companies. This type of contract manufacturing is witnessing a rising trend as more and more pharma companies are trying to focus more on R&D of drugs rather than getting involved in the production of drugs in order to gain competitive advantage in the business. This industry is classified into API manufacturing and Finished Dosage formulation(FDF) manufacturing.
This report elaborates the market size, market characteristics, and market growth of the Contract Pharmaceutical Manufacturing industry, and breaks down according to the type, application, and consumption area of Contract Pharmaceutical Manufacturing. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Contract Pharmaceutical Manufacturing in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Contract Pharmaceutical Manufacturing market covered in Chapter 11:
AbbVie
Aesica
NextPharma
Jubilant
Lonza
Famar
Recipharm
Aenova
Sopharma
Catalent
Dishman
Piramal Healthcare
Vetter
DPT Laboratories
Boehringer Ingelheim
DPx
Nipro Corp
Fareva Holding
In Chapter 3, on the basis of types, the Contract Pharmaceutical Manufacturing market from 2015 to 2025 is primarily split into:
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
In Chapter 4, on the basis of applications, the Contract Pharmaceutical Manufacturing market from 2015 to 2025 covers:
Development
Manufacturing
Testing
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
2019
This report elaborates the market size, market characteristics, and market growth of the Contract Pharmaceutical Manufacturing industry, and breaks down according to the type, application, and consumption area of Contract Pharmaceutical Manufacturing. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Contract Pharmaceutical Manufacturing in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Contract Pharmaceutical Manufacturing market covered in Chapter 11:
AbbVie
Aesica
NextPharma
Jubilant
Lonza
Famar
Recipharm
Aenova
Sopharma
Catalent
Dishman
Piramal Healthcare
Vetter
DPT Laboratories
Boehringer Ingelheim
DPx
Nipro Corp
Fareva Holding
In Chapter 3, on the basis of types, the Contract Pharmaceutical Manufacturing market from 2015 to 2025 is primarily split into:
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
In Chapter 4, on the basis of applications, the Contract Pharmaceutical Manufacturing market from 2015 to 2025 covers:
Development
Manufacturing
Testing
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
